ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)

CUSIP: 04280A100

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
135,488,140
Total 13F shares
115,950,686
Share change
+4,825,104
Total reported value
$7,698,651,817
Put/Call ratio
28%
Price per share
$66.39
Number of holders
397
Value change
+$347,299,438
Number of buys
237
Number of sells
135

Quarterly Holders Quick Answers

What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q4 2025

As of 31 Dec 2025, ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by 397 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 115,950,686 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, FMR LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Slate Path Capital LP, BAKER BROS. ADVISORS LP, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and FRED ALGER MANAGEMENT, LLC. This page lists 397 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.